$EWTX

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3d)

-0.3%

Win rate (3d)

100% (2 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$EWTXSEC Form 4bearish

Russell Alan J · Chief Scientific Officer at Edgewise Therapeutics, Inc. · 47d agono track record yet

Sold 5,901 @ $43.73 avg · $258,042 · 2026-08-12

Form 4: Russell Alan J sold EWTX

Russell Alan J (Chief Scientific Officer at Edgewise Therapeutics, Inc.) reported an open-market sale of 5,901 shares of EWTX at an average $43.73, roughly $258,042, in a Form 4 filed 2026-08-14.

At post $44.17Now $45.32+2.6% since postedas of Sep 18, 4:30 PM ET

1d—

3d-0.3%

1w+0.0%

1m+0.5%

3m—

6m—

1y—

View filing on SEC.gov →

$EWTXSEC Form 4bearish

KOCH KEVIN · President and CEO at Edgewise Therapeutics, Inc. · 47d agono track record yet

Sold 17,971 @ $43.68 avg · $785,042 · 2026-08-12

Form 4: KOCH KEVIN sold EWTX

KOCH KEVIN (President and CEO at Edgewise Therapeutics, Inc.) reported an open-market sale of 17,971 shares of EWTX at an average $43.68, roughly $785,042, in a Form 4 filed 2026-08-14.

At post $44.17Now $45.32+2.6% since postedas of Sep 18, 4:30 PM ET

1d—

3d-0.3%

1w+0.0%

1m+0.5%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.